drugset / Trial / NCT02214966

Influence of Food on the Bioavailability of Telmisartan / Ramipril Fixed Dose Combination in Healthy Male and Female Volunteers

NCT02214966

Phase 1 Completed 42 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

The objective was to investigate the relative bioavailability of the fixed dose combination (FDC) tablet (80 mg telmisartan / 10 mg ramipril) after food intake in comparison to the bioavailability of the FDC tablet while fasting.

Timeline

Start
2007-10
Primary completion
2007-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Ramipril Small molecule 10 mg
Subject Telmisartan Other / unclassified 80 mg

Indications

No indication recorded.